Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News, archive: March 2017

3/17/2017 Database Update: Pharmaceutical Drug Import to Russia (February 2017)

In January and February 2017, Russia imported 63.7 bln RUB worth of ready-made drugs (free circulation prices) and 14.5 bln RUB worth of in-bulk drugs, which are 4% and 51% higher than those of the same period of 2016, respectively. In monetary terms, the total import of pharmaceutical drugs has increased by 11% over the first two months of 2017.

3/13/2017 Rating of Russian Pharmaceutical Distributors (2016)

Just some 2-3 years ago, the wholesale trade of pharmaceuticals seemed long established. The leaders fought for tenths of a percent, slowly diversified, and if someone left the race, it was due to understandable and even expected reasons. However, the financial crisis changed absolutely everything.